Alyeska Investment Group, L.P. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 85 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2015$6,084,000
+153.5%
346,124
+115.8%
0.04%
+6.1%
Q1 2015$2,400,000
+77.9%
160,406
+38.1%
0.03%
+43.5%
Q4 2014$1,349,000
+17.0%
116,188
+17.4%
0.02%
-4.2%
Q3 2014$1,153,000
+15.2%
98,974
-1.0%
0.02%
+9.1%
Q2 2014$1,001,000100,0000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders